Novavax Requests Expanded Authorization of Nuvaxovid COVID-19 Vaccine to Adolescents Aged 12 through 17 Years in Great Britain Read more
Novartis Kymriah receives EC approval as first CAR-T cell therapy for adults with relapsed or refractory follicular lymphoma Read more
Amphista Therapeutics Enters Strategic Collaboration with Merck for Discovery and Development of Targeted Protein Degradation Therapeutics Read more
Sapience Therapeutics Receives FDA Orphan Drug Designation for ST101 for the Treatment of Advanced Melanoma Read more
Agastiya Biotech receives FDA Orphan Drug Designation for AB001 for Pancreatic cancer and Acute Myeloid Leukemia (AML) Read more
STORM Therapeutics Awarded Innovate UK Grant to Discover and Develop a Novel Coronavirus Therapy Targeting an RNA-Modifying Enzyme Read more
Genesis Therapeutics Announces Strategic Collaboration with Lilly to Discover Novel Therapies Using the Genesis Molecular AI Platform Read more
Nicoya Completes Acquisition of LSK Technologies, Expanding Digital Platform into Molecular Testing Read more
Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar Read more